Paciente pediátrico crítico. Cuidados Intensivos Pediátricos, Hospital Infantil La Paz / Critical pediatric patient. Pediatric intensive cares, Hospital Infantil La Paz

Los Cuidados Intensivos Pediátricos (CIPs) iniciaron su actividad en el Hospital Infantil La Paz en el año 1074. El servicio actual dispone de 16 camas, cuatro de cuidados medios, ocho de cuidados intensivos y cuatro de aislamiento con exclusa y filtros HEPA (High Efficiency Particulate Air). En los últimos 6 años (2006-2010) se han atendido 3.674 pacientes, media de 612 pacientes año, con una ocupación media anual del 83,4% y mortalidad media anual del 4,9%. Al ser considerado un servicio polivalente, se ha establecido una estrecha colaboración prácticamente con la totalidad de los servicios y especialidades pediátricas médico-quirúrgicas del hospital, con mayor o menor frecuencia según las patologías asistidas, destacando entre las patologías asistidas, destacado entre las patologías quirúrgicas los pacientes con asistencia ventricular (Berlin Hear), ECMO (Extracorporeal Membrane Oxygenation) y trasplante cardiaco; así como tratamiento psotoepratorio de los trasplantes hepáticos, renales, intestinales y multiviscerales. Entre las líneas de trabajo, hay que destacar el tratamiento intracoronario con células progenitoras autólogas de médula ósea en pacientes con miocardiopatía dilatada e insuficiencia cardíaca; creación de un equipo mixto, médico y de enfermería para el abordaje guiado por ecografía, de accesos venosos centrales insertados periféricamente; registro de una patente europea de válvula de cierre ultrarrápido y sin fugas para respiradores; utilización a nivel pediátrico de la tecnología ventilatoria NAVA (Neurally Adjusted Ventilatory Asist); monitorización hemodinámica con el monitor PiCCO2 (Pulsion Medical System); la promoción de la ecuación médica basada en la simulación de ata fidelidad y la implantación de la asistencia ventricular externa en Pediatría (AU)

The Pediatric Intensive Care Unit of La Paz Universitary Hospital, was founded in 1974. It is now a polyvalent medical-surgical tertiary unit, equipped with 4 intermediate care beds, 8 intensive care beds and 4 isolation beds with airlock and HEPA filters for the treatment of transplanted and immunocompromised patients. In the last 6 years, 3674 patients have been treated (mean 612 patients/year) with a mean occupancy rate of 83,4% and a mortality rate of 4,9&. As the polyvalent unit it is, PICU staff maintains close and daily contact and cooperation with almost all the rest of the medical and surgical departments of the hospital. In this regard Critically ill cardiac patients are admitted in the PICU ( for the treatment with ECMO and ventricular assist devices (EXCOR Berlin Heart), as well as post-operative patients after cardiac, liver, renal, intestinal and multivisceral transplantation. Of all the achievements and current lines of work of the department, it can be highlighted the intracoronary treatment with autologous bone marrow derived progenitor cells in patients with dilated cardiomyopathy, the implantation development of a pediatric ventricular assist program, the echo guided cannulation of peripherally inserted central venous catheter by a especially trained intravenous therapy team, the registration of a European patent for a ultrarapid shutoff respirator valve, the incorporation of NAVA mode for mechanically ventilated patients and the PiCCO2 monitor for the hemodynamic monitorization of patient with cardiovascular dysfunction, and the promotion of medical education based on high-fidelity simulation (AU)

[Care of the critically ill child with heart disease in Spain]. / La asistencia al niño crítico con cardiopatía en España.

INTRODUCTION: The objective of the present study is to present the organization of the resources of paediatric cardiac critical care in Spain. PATIENTS AND METHODS: Data were collected through questionnaires sent by e-mail to Spanish PICUs. RESULTS: 22 PICUs were enrolled. The median number of beds were 9.5 (4-18 beds). Total cardiac admissions represented a 20 % of total PICUs admissions per year, firstly for congenital heart defects, and secondly for respiratory problems. Cardiac surgical activities were carried out in 16 centres, centralized in PICU in 10 cases. Mechanical support of the myocardium was performed in 7 PICUs. A total of 10 participating PICUs considered echocardiograph training necessary and also an increase in the amount of activity for better results. CONCLUSIONS: Paediatric cardiac critical care involves a significant use of resources, including PICUs with no surgical activity. This study is useful for detecting common problems and for improving clinical care.

[Pneumococcal conjugate vaccine failure in HIV-infected child. Clinical case]. / Fallo de la vacuna antineumocócica conjugada en un niño VIH positivo. A propósito de un caso.

Despite appropriate antimicrobial therapy and vaccination, invasive pneumococcal infections remain associated with significant mortality, especially in selected high-risk groups (asplenic, humoral immunity deficient patients, etc.). We present a 13-year-old caucasian boy with HIV infection (vertical transmission). He received treatment with highly-active antiretroviral therapy (amprenavir, lamivudine and zidovudine) and vaccination with 23-valent vaccine (6 years old) and 7-valent pneumococcal conjugate vaccine (10 years old). His CD4 count and his viral load at these times were 2,063/microl and 13461 cop/ml, when he was 6 years old and 1,315/microl and 32400 cop/ml when he was 10 years old, respectively. The latest CD4 count (1,000/microl) and his viral load (3800 cop/ml) confirmed satisfactory control of the disease. He was referred to our emergency department presenting with fever, head and stomach-ache and vomiting. In the following hours his condition continued to deteriorate and depressed level of consciousness and meningismus were observed. Streptococcus pneumoniae, serotype 18 C, was detected in blood and cerebrospinal fluid cultures. Despite appropriate treatment with antibiotics (cefotaxime and vancomycin) and anti-oedema medications, brain-death was confirmed 24 hours after his admittance.

La asistencia al niño crítico con cardiopatía en España / Care of the critically ill child with heart disease in Spain

Introducción: Los niños con cardiopatía constituyen una causa frecuente de ingreso en UCIP. El objetivo de este estudio es conocer la organización de su asistencia en España. Pacientes y métodos: Se elaboró un cuestionario que se envió por correo electrónico a todas las UCIP englobadas en la Sociedad Española de Cuidados Intensivos Pediátricos. Resultados: Contestaron la encuesta 22 UCIP, con una mediana de camas de 9,5 (rango 4-18). Los ingresos de niños críticos con cardiopatía representaron el 20 % del total de ingresos anuales en las UCIP con actividad cardioquirúrgica y hasta el 10 % en UCIP sin dicha actividad. Las causas de ingreso más frecuentes fueron las cardiopatías congénitas (coartación aórtica y defectos de septo) y, en segundo lugar, problemas no cardiológicos (fundamentalmente infecciones respiratorias). Asisten el postoperatorio de cirugía cardíaca infantil 16 UCIP (4 unidades tienen programa de trasplante cardíaco pediátrico), 10 de ellas de forma centralizada en su centro. Un total de 7 unidades disponen de medios de soporte mecánico miocárdico; 10 de las UCIP encuestadas consideraron muy importante adquirir formación en ecocardiografía, así como la agrupación de los pacientes en áreas especializadas. Conclusiones: La atención al niño crítico con cardiopatía supone una utilización importante de recursos en las UCIP, incluidas aquellas que no atienden postoperatorios cardíacos. Este tipo de estudios permite identificar limitaciones comunes y favorecer la asistencia de este tipo de pacientes (AU)

Introduction: The objective of the present study is to present the organization of the resources of paediatric cardiac critical care in Spain. Patients and methods: Data were collected through questionnaires sent by e-mail to Spanish PICUs. Results: 22 PICUs were enrolled. The median number of beds were 9.5 (4-18 beds). Total cardiac admissions represented a 20 % of total PICUs admissions per year, firstly for congenital heart defects, and secondly for respiratory problems. Cardiac surgical activities were carried out in 16 centres, centralized in PICU in 10 cases. Mechanical support of the myocardium was performed in 7 PICUs. A total of 10 participating PICUs considered echocardiograph training necessary and also an increase in the amount of activity for better results. Conclusions: Paediatric cardiac critical care involves a significant use of resources, including PICUs with no surgical activity. This study is useful for detecting common problems and for improving clinical care (AU)

Fallo de la vacuna antineumocócica conjugada en un niño VIH positivo. A propósito de un caso / Pneumococcal conjugate vaccine failure in HIV-infected child

La infección neumocócica sigue asociada con una importante mortalidad, especialmente en grupos de riesgo (esplenectomizados, déficit de la inmunidad humoral, etc.) a pesar de vacunas y antibióticos adecuados. Presentamos a un niño de 13 años VIH positivo por transmisión vertical tratado con triple terapia (amprenavir, lamivudina y zidovudina). Fue vacunado con vacuna 23-valente a los 6 años y conjugada heptavalente a los 10 años de edad. El recuento de células CD4 y su carga viral a los 6 años eran de 2.063/μl y 13.461 copias/ml, respectivamente. A los 10 años el recuento de CD4 y su carga viral eran de 1.315/μl y 32.400 copias/ml, respectivamente. El último recuento de CD4 (1.000/μl) y la carga viral (3.800 copias/ml) confirmaban un buen control de la enfermedad 15 días antes del ingreso. Acude a urgencias por fiebre, dolor abdominal y vómitos. Hay un progresivo deterioro del nivel de conciencia y signos meníngeos. En el hemocultivo y en el cultivo de LCR crece Streptococcus pneumoniae serotipo 18C, y es tratado con cefotaxima y vancomicina, así como medidas antiedema cerebral, pero evoluciona a muerte cerebral en 24 h (AU)

Despite appropriate antimicrobial therapy and vaccination, invasive pneumococcal infections remain associated with significant mortality, especially in selected high-risk groups (asplenic, humoral immunity deficient patients, etc.). We present a 13-year-old caucasian boy with HIV infection (vertical transmission). He received treatment with highly-active antiretroviral therapy (amprenavir, lamivudine and zidovudine) and vaccination with 23-valent vaccine (6 years old) and 7-valent pneumococcal conjugate vaccine (10 years old). His CD4 count and his viral load at these times were 2,063/μl and 13461 cop/ml, when he was 6 years old and 1,315/μl and 32400 cop/ml when he was 10 years old, respectively. The latest CD4 count (1,000/μl) and his viral load (3800 cop/ml) confirmed satisfactory control of the disease. He was referred to our emergency department presenting with fever, head and stomach-ache and vomiting. In the following hours his condition continued to deteriorate and depressed level of consciousness and meningismus were observed. Streptococcus pneumoniae, serotype 18 C, was detected in blood and cerebrospinal fluid cultures. Despite appropriate treatment with antibiotics (cefotaxime and vancomycin) and anti-oedema medications, brain-death was confirmed 24 hours after his admittance (AU)

[Fisher's index as indicator of severity and its course in the postoperative period following liver transplantation in children]. / Indice de Fisher como indicador de gravedad y su evolución en el postoperatorio inmediato del trasplante hepático en niños.

OBJECTIVES: To study the evolution of Fisher index during the early postoperative period after liver transplantation in children. PATIENTS AND METHODS: We have studied 32 liver transplants performed on 26 pediatric patients, during the first week of the post-operative period. In all cases the BCAA/AAA quotient was determined before transplant, at the time of PICU admission, and on days 1, 2, 3, 4, 5, 6 and 7 after transplant. RESULTS: Compared to control group values, the Fisher index for these patients is significantly lower at pre-transplant (p < 0,0001), upon admission (p < 0,001), and days 1 (p < 0,0001), 2 (p < 0,0001) and 3 (p < 0, 0001). Comparison between non-survivors and survivors shows a significant reduction in the first group on the index in days 1 (p < 0,02), 3 (p < 0,02), 4 (p < 0,005), 5 (p < 0,002), 6 (p < 0,03) and 7 (p < 0,01) of post-transplant. CONCLUSIONS: The evolution of the Fisher index can be useful as an indication of the severity of the condition of these kinds of patients, which would help to establish more aggressive treatment to improve prognosis.

Índice de fisher como indicador de gravedad y su evolución en el postoperatorio inmediato del trasplante hepático en niños / Fisher's index as an indicator of severity and its evolution in the postoperative period following liver transplantation in children

OBJETIVO: Estudiar la evolución del índice de Fisher y su utilidad como indicador de gravedad, durante el postoperatorio inmediato de pacientes pediátricos sometidos a un trasplante de hígado. PACIENTES Y MÉTODOS: El estudio comprende 32 trasplantes de hígado realizados en 26 niños. En todos los casos el índice BCAA/AAA fue determinado antes del trasplante, al ingreso postrasplante y los días 1, 2, 3, 4, 5, 6 y 7 después del trasplante. RESULTADOS: Comparado con el grupo control, el índice de Fisher de los pacientes fue significativamente más bajo en el pretrasplante (p < 0,0001), al ingreso (p < 0,001) y los días 1 (p < 0,0001), 2 (p < 0,0001) y 3 (p < 0,0001). Al comparar el grupo de pacientes vivos con el grupo de pacientes fallecidos, se evidencia una disminución significativa en el grupo de pacientes fallecidos los días 1 (p < 0,02), 3 (p < 0,02), 4 (p < 0,005), 5 (p < 0,002), 6 (p < 0,03) y 7 (p < 0,01). CONCLUSIÓN: La evolución del índice de Fisher puede servir como parámetro indicador de gravedad en pacientes pediátricos sometidos a un trasplante de hígado, lo que permitiría establecer un tratamiento más intensivo que pudiera mejorar el pronóstico de estos enfermos (AU)

[Desquamative interstitial pneumonia]. / Neumonía intersticial descamativa.

Authors describe a case of desquamative interstitial pneumonia in a seven month old boy. Initial manifestations were anorexia, feeding difficulties, retarded ponderal and progressive respiratory distress. Pathologic diagnosis was performed by open pulmonary biopsy. He was treated with steroids and followed a severe clinical course dying at 9 months of age. Etiopathogenesis, diagnosis and treatment as well as cases published in pediatric literature are reviewed.

[Diabetic ketoacidosis and coma. Insulin perfusion (author's transl)]. / Cetoacidosis y coma diabético. Tratamiento con perfusión contínua de bajas dosis de insulina y actualización terapéutica.

Ten cases of diabetic ketoacidosis treated by low-dose insulin continuous perfusion are reported. The severe period therapeutic guide is exposed in two stages showing the form of correction of the most important ketoacidosis. Insulin doses have been, initially, 0.1 U./Kg. in a bolus, followed by 0.1-0.01 U./Kg./h. till acidosis and dehydration are corrected. Evolution of every case was good, without any important complication. Advantages of this therapeutic modality are appointed: an easy treatment management, lesser glycaemia oscillations and lesser complications than using the conventional method of intermittent high doses. In order to overcome, the acidosis and hyperglicaemia resistance found in some of the severest cases, authors suggest to increase the dose of perfused insulin as well as hydration, Finally, the importance of control and patient care is stressed, recommending their admission to a Paediatric Intensive Care unit.

[Intrauterine renal vein thrombosis (author's transl)]. / Trombósis venosa renal intrauterina.

One case of renal venous thrombosis in a male foetus, born of a diabetic mother is reported. The intrauterine origin and the long age of the thrombosis were confirmed by pathologic studies. Some speculation about the etiopathogenic mechanisms of intrauterine renal venous thrombosis are made.